C4C+: Exercise for Oncology Care Professionals

Sponsor
Melanie Keats (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05884073
Collaborator
(none)
36
1
3
12
3

Study Details

Study Description

Brief Summary

The goal of this preference-based pilot study will be to assess the feasibility, acceptability, and impact of a 12-week exercise intervention on oncology care provider burnout, compassion fatigue, and well-being. Participants will be divided into one of three exercise groups. Group assignment will be based on participant preference.

Group 1: Supervised circuit-based resistance exercise (2 days/week)

Group 2: Supervised circuit-based resistance exercise (2 days/week) + moderate-to-high intensity home-based walking/light jogging program (3 days/week)

Group 3: Self-paced home-based walking program (3 days/week)

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Circuit-based Resistance Training
  • Behavioral: Circuit-based Resistance Training + Home-based Walking
  • Behavioral: Home-based Walking
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
36 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Cost of Caring: Examining the Role of Exercise in Mitigating Oncology Care Provider Burnout (C4C+)
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Aug 31, 2024
Anticipated Study Completion Date :
Aug 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Circuit-based resistance exercise

12-week, supervised twice weekly circuit-based resistance training program.

Behavioral: Circuit-based Resistance Training
Participants will engage in a 12-week, twice weekly circuit-based resistance training program. Each supervised session will last about 25 minutes and will consist of 5 resistance exercises. Each exercise will be completed for 1 minute for a total of 5 minutes followed by a 1-minute rest. The circuit will then repeated 3 additional times (total of 4 circuits). All resistance sessions will be supervised by a certified fitness professionals.

Experimental: Circuit-based resistance exercise plus home-based walking

12-week, supervised twice weekly circuit-based resistance training program plus home-based (unsupervised) brisk walking/light jogging program 3 days/week.

Behavioral: Circuit-based Resistance Training + Home-based Walking
Participants will engage in a 12-week, twice weekly circuit-based resistance training program. Each supervised session will last about 25 minutes and will consist of 5 resistance exercises. Each exercise will be completed for 1 minute for a total of 5 minutes followed by a 1-minute rest. The circuit will then repeated 3 additional times (total of 4 circuits). All resistance sessions will be supervised by a certified fitness professionals. Participants will also be asked to engage in 25 minutes of brisk power walking or light jogging at home (unsupervised) 3 days/week for 25 minutes on days when they have not engaged in resistance training.

Active Comparator: Home-based walking

12-week self-paced walking at home (unsupervised) 3 days/week.

Behavioral: Home-based Walking
Participants will be asked to engage in 25 minutes of self-paced walking at home (unsupervised) 3 days/week.

Outcome Measures

Primary Outcome Measures

  1. Feasibility - Recruitment [Through study completion (about 1 year)]

    Participant accrual as defined as the number of eligible participants who consent to participate.

  2. Feasibility - Participant Fidelity (Intervention Adherence) [Through study completion (about 1 year)]

    Participant adherence to prescribed exercise intervention

  3. Feasibility - Safety [Through study completion (about 1 year)]

    Adverse and serious adverse events

  4. Feasibility - Retention/Attrition [Through study completion (about 1 year)]

    Percentage of participants who complete the 12-week intervention

  5. Feasibility - Participant Experience [Through study completion (about 1 year)]

    Exit interview is used to assess factors influencing participant selection of intervention type/setting, adherence to and satisfaction with the selected intervention.

  6. Feasibility - Attendance [Through study completion (about 1 year)]

    Attendance is calculated as the percentage of exercise sessions completed by the total number of available exercise sessions over the 12-week intervention.

Secondary Outcome Measures

  1. Maslach Burnout Inventory (MBI) for Medical Personnel (MP) [Pre to post intervention (12-week change)]

    The MBI-MP is used to assess burnout in medical professionals. The 22-item, 7-point Likert scale (0 = never to 6 = everyday) assesses burnout across three dimensions: emotional exhaustion (9 items), personal accomplishment (8 items), and depersonalization (5-items).

  2. Professional Quality of Life Scale (ProQOL) [Pre to post intervention (12-week change)]

    The 30-item ProQOL is used to assess compassion fatigue (10 items), compassion satisfaction (10 items), and burnout (10 items). Items are scored on a 5-point Likert scale (1 = never to 5 = very often).

  3. Depression, Anxiety, and Stress Scale - Short Version (DASS21) [Pre to post intervention (12-week change)]

    The 21-item DASS is used to assess symptoms associated with three negative emotional states: depression, anxiety, and stress. Each scale contains 7-items scored on a 4-point severity/frequency scale.

  4. Physical Activity Behavior - Daily step count [Week 1 through Week 12]

    Participants asked to record their daily step counts using a wrist worn activity monitor.

  5. Physical Activity Behavior - Self-reported [Pre to post intervention (12-week change)]

    Self-reported physical activity is assessed by the Godin Leisure Time Exercise Questionnaire. Higher scores indicate higher levels of physical activity. Participants reporting moderate-to-strenuous Leisure Score Index ≥ 24 are classified as active; those reporting moderate-to-strenuous Leisure Score Index ≤ 23 are classified as insufficiently active.

  6. Resting heart rate [Pre to post intervention (12-week change)]

    Resting heart rate

  7. Resting Blood Pressure [Pre to post intervention (12-week change)]

    Resting systolic and diastolic blood pressure

  8. Aerobic fitness [Pre to post intervention (12-week change)]

    The six-minute walk test is used to assess aerobic capacity.

  9. Upper Body Strength [Pre to post intervention (12-week change)]

    A hand-held dynamometer is used to assess upper body strength.

  10. Muscular Endurance [Pre to post intervention (12-week change)]

    The 30-second sit-to-stand is used to assess lower body muscular endurance.

  11. Body Mass Index [Pre to post intervention (12-week change)]

    Height and weight is used to assess body mass index

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years of age or older

  • Must be providing formal (paid) care to cancer patients in a clinical setting

  • Actively practicing within the Nova Scotia Cancer Care Program

Exclusion Criteria:
  • Exceeding Canadian physical activity guidelines of 150-minutes of moderate-to-vigorous physical activity per week

  • Any health condition that would preclude safe participation in a new exercise program

Contacts and Locations

Locations

Site City State Country Postal Code
1 Physical Activity and Cancer (PAC) Lab Halifax Nova Scotia Canada B3H 2Y9

Sponsors and Collaborators

  • Melanie Keats

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Melanie Keats, Principal Investigator, Nova Scotia Health Authority
ClinicalTrials.gov Identifier:
NCT05884073
Other Study ID Numbers:
  • C4C+
First Posted:
Jun 1, 2023
Last Update Posted:
Jun 1, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Melanie Keats, Principal Investigator, Nova Scotia Health Authority
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 1, 2023